These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16087396)

  • 1. Antisense approaches to immune modulation for transplant and autoimmune diseases.
    Mourich DV; Marshall NB
    Curr Opin Pharmacol; 2005 Oct; 5(5):508-12. PubMed ID: 16087396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splicing in the immune system: potential targets for therapeutic intervention by antisense-mediated alternative splicing.
    Mourich DV; Iversen PL
    Curr Opin Mol Ther; 2009 Apr; 11(2):124-32. PubMed ID: 19330718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antisense oligonucleotides: a new therapeutic approach].
    Guinot P; Temsamani J
    Pathol Biol (Paris); 1998 May; 46(5):347-54. PubMed ID: 9769897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Applications of antisense oligonucleotides in oncology].
    Pierga JY; Cammilleri S; Benyahia B; Magdelénat H
    Bull Cancer; 1994 Dec; 81(12):1023-42. PubMed ID: 7742591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating autoimmune diseases through restoration of antigen-specific immune tolerance.
    Wolfraim LA
    Arch Immunol Ther Exp (Warsz); 2006; 54(1):1-13. PubMed ID: 16642252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infections and autoimmune diseases.
    Bach JF
    J Autoimmun; 2005; 25 Suppl():74-80. PubMed ID: 16278064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy in autoimmune diseases: challenges and opportunities.
    Leung PS; Dhirapong A; Wu PY; Tao MH
    Autoimmun Rev; 2010 Jan; 9(3):170-4. PubMed ID: 19854300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular and clinical rationale of extracorporeal photochemotherapy in autoimmune diseases, malignancies and transplantation.
    Szodoray P; Papp G; Nakken B; Harangi M; Zeher M
    Autoimmun Rev; 2010 Apr; 9(6):459-64. PubMed ID: 20044039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression.
    Wan YY; Flavell RA
    Nature; 2007 Feb; 445(7129):766-70. PubMed ID: 17220876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical experience of antisense therapy to ICAM-1 in Crohn's disease.
    Yacyshyn B; Bowen-Yacyshyn MB; Shanahan W
    Curr Opin Mol Ther; 1999 Jun; 1(3):332-5. PubMed ID: 11713798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regulatory T cells].
    Marinić I; Gagro A; Rabatić S
    Acta Med Croatica; 2006 Dec; 60(5):447-56. PubMed ID: 17217101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense oligonucleotide-based therapeutics for cancer.
    Dean NM; Bennett CF
    Oncogene; 2003 Dec; 22(56):9087-96. PubMed ID: 14663487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense strategies for oncogene inactivation.
    Stein CA; Benimetskaya L; Mani S
    Semin Oncol; 2005 Dec; 32(6):563-72. PubMed ID: 16338422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rejection and acceptance of corneal allografts.
    Klebe S; Coster DJ; Williams KA
    Curr Opin Organ Transplant; 2009 Feb; 14(1):4-9. PubMed ID: 19337139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense technology and prospects for therapy of viral infections and cancer.
    Wagner RW; Flanagan WM
    Mol Med Today; 1997 Jan; 3(1):31-8. PubMed ID: 9021740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antisense nucleotides for therapy].
    Wang J; Wang L; Wang Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Feb; 23(1):230-4. PubMed ID: 16532848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense therapy in malignant diseases: status quo and quo vadis?
    Tamm I
    Clin Sci (Lond); 2006 Apr; 110(4):427-42. PubMed ID: 16526947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of antibody treatment on regulatory CD4(+)CD25(+) T cells.
    Yi H; Zhang J; Zhao Y
    Transpl Immunol; 2008 Apr; 19(1):37-44. PubMed ID: 18346636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of Antisense Drugs.
    Bennett CF; Baker BF; Pham N; Swayze E; Geary RS
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():81-105. PubMed ID: 27732800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense applications for biological control.
    Pan WH; Clawson GA
    J Cell Biochem; 2006 May; 98(1):14-35. PubMed ID: 16440307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.